Trinity biotech plc reports qtrly diluted earnings per adr of $0.09

Trinity biotech plc - we are beginning to see some negative impact on our revenues due to covid-19 pandemic.trinity biotech plc - covid-19 pandemic will have an impact on our quarter 1 revenues and more so in quarter 2.trinity biotech plc - expect revenues to rebound quickly and for there to be no long term impact.trinity biotech plc qtrly diluted earnings per adr $0.09.trinity biotech plc qtrly revenue $21.3 million versus $24.5 million.trinity biotech plc - have made decision to close our manufacturing plant in carlsbad, california on june 30, 2020.trinity biotech plc - close to completing development of an elisa test for detection of antibodies to the virus that causes covid-19.
TRIB Ratings Summary
TRIB Quant Ranking